Found 8 matching trials
Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence
PHASE3Phase III, randomized, double-blind, double-dummy, active-controlled, paral...
Location
Parkway Medical Center
Long-acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-involved Adults
PHASE4This study seeks to compare the effectiveness of two medications used to tr...
Location
Yale University School of Medicine
Monthly Versus Daily Buprenorphine Formulations for Treatment of Opiate Use Disorder
PHASE4Opioid use disorder and opioid-related deaths are increasing across Canada....
Location
Royal Victoria Regional Health Centre
Virginia Opioid Overdose Treatment InitiatVE
PHASE3This is a Phase 3b, open-label study in patients that present to the ED for...
Location
Virginia Commonwealth University
Evaluation of Long-term Buprenorphine Plasma Exposure
N/AThe study objective is to characterise the long-term plasma exposure to bup...
Location
Pathway Healthcare
Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects
PHASE2This is an open-label study in treatment seeking opioid-dependent subjects ...
Location
Vince and Associates Clinical Research
Open-Label Treatment Extension Study
PHASE3Study is to provide ongoing treatment with RBP-6000 and safety monitoring f...
Location
Boyett Health Services
Virginia Opioid Treatment-Emergency Department
PHASE3The current study seeks to test the feasibility of an alternative treatment...
Location
Multiple Locations